Education/Research

University Hospital Cincinnati Transplant Center and UC researchers are conducting ongoing initiatives in several areas, with focus primarily based on regimens to remove obstacles to transplant:  desensitization, treatment of antibody-mediated rejection using Velcade (bortezimob) – creating national interest – and our decade-long experience with steroid-free immunosuppression, pioneered here at University of Cincinnati and in our renal transplant programs.

Data shows that our steroid-free regimens have resulted in increased graft survival and patient survival rates, in addition to improved quality of life with fewer steroid-related side effects. 

Our researchers routinely present breakthrough findings in genetic and molecular sciences relating to transplantation, including immunosuppression in manipulating the immune response to minimize graft rejection, and prevention and treatment of adverse events, at leading national and international research society meetings, such as the American Transplant Congress and the International Congress of the Transplantation Society.



Search this site

  • Opportunities for Patients to Participate in Clinical Research

    University Hospital Cincinnati Transplant Center offers patients the opportunity to participate in clinical trials, or research studies. Clinical trials related to organ transplantation may study ways to improve graft acceptance and patient survival, treat or prevent complications related to transplant or develop new tests to help with early diagnosis and monitoring of conditions that lead to complications.

    If you’d like more information about research studies currently underway at University Hospital of Cincinnati Transplant Center, or about participating in a research study related to transplantation, please contact University Hospital of Cincinnati Transplant Center’s Clinical Research Division at (513) 558-1568.